New Patent Registration

February 4, 2025

đź’ˇ What? 

Vita Motus has registered a new patent describing a new approach to smoothly correct atherosclerosis epigenesis using Angelica extract.

🏆 How?

Angelica extract modifies the microRNA profile in human plasma by lowering the expression levels of microRNAs that promote atherosclerosis while increasing the levels of molecules that inhibit atherosclerosis.

🚀 Why is this important? 

Thus, it is possible to incorporate plant extract intake into daily life and gain all the natural health benefits without side effects.

Targeting Extracellular Vesicles 2025 congress in Valencia

🧬 Exploring the Future of Extracellular Vesicle Science This month, we attended the Targeting Extracellular Vesicles

Hello Ilmac Basel 2025

We were delighted to attend Ilmac Basel 2025 again! This year’s focus on AI & digital

New ISO Certification

🏆 We’re proud to share that Vita Motus AG has once again been awarded the ISO